Alongside the FDA’s orphan drug designation in the U.S., the European Commission’s orphan medicinal product designation for mitapivat underscores the urgent need for novel therapies for sickle cell ...
About 800,000 people experience a stroke each year in the U.S., and due to recent advances in acute treatment, more people survive. Many stroke survivors experience long-term physical, mental and ...